Services
- Prioritization and evaluation of new targets
- Identification and design of experiments for ideas and hypothesis testing
- Identification of optimal PK/PD properties for compounds
- Optimization of dose, regimen, and study duration for early stages of clinical trials
- Optimization of clinical study designs
- Prediction of human efficacy for compounds based on preclinical data (Translational medicine)
- Prediction of compound tissue distribution (PBPK)
- Identification and validation of combination therapies
- Prioritization of biomarkers
- Analysis of clinical study failure
- Prediction of new entities of marketed drugs
- Explanation of reasons and prediction of responders and nonresponders
- Investigation of the mechanism of action of compounds
- Optimization of conditions for biotechnology processes (pH, temperature, substrate renewal, periodicity, etc.)
- Development of control systems/software for bioreactors
- Prediction of the productivity of bacterial strains with the expression of recombinant protein